KOOPrime is one of the first software companies to provide component-based solutions and services to the life sciences industry. We provide an integrative platform capable of linking heterogeneous businesses, software, hardware, and human processes through the use of components. We also provide toolsets of components that can streamline Internet data collection, high-throughput data processing and data visualisation.
Our technologies have been successfully applied in a number of key verticals. The bioresearch vertical includes organizations that perform biomolecular research and provide services for biomedical and agricultural-veterinary purposes. Within the pharmaceutical vertical, KOOPrime delivers knowledge management systems for drug discovery, pre-clinical research and clinical trial purposes. In the healthcare vertical, KOOPrime builds tissue registries, HL7 exchange system and clinical studies systems for hospitals and health ministries.
In Sep 2006, the HKUST-KOOPrime-HP Bioinformatics Centre was setup at Hong Kong to focus on Chinese medicine and infectious diseases. A subsidiary, KOOPrime Consulting, was also formed to complement and provide validation services for GXP compliance across the life science industry.
KOOPrime has established presence in various Asian countries, in particular, Singapore, Japan, Malaysia, Thailand, Taiwan, China and India, and also an operation in US. The key shareholders include National University of Singapore, Merlion Pharmaceuticals Pte Ltd, Glaxo Smith Kline Manufacturing and Bio*One Capital Pte Ltd. (investment arm of EDB)